Subscribe to RSS
DOI: 10.1055/a-2627-4183
Plant-derived Bioactive Substances with Anti-rheumatoid Arthritis Properties
Authors
This research was funded by the National Natural Science Foundation of China, grant number 31800688, China Scholarship Council, grant number No. 202406800020, the Foundation of Liaoning Educational Committee of China, grant number JYTMS20230765, the Science and Technology Project of Department of Science & Technology of Liaoning province of China, grant number 2024-MSLH-185, the Shenyang Youth Science and Technology Innovation Project, grant number RC220177, and the Screening of small-molecule tumor suppression compounds project, grant number SDUZHHT (2022) 2448 to Zhe Yang, as well as the Foundation of Liaoning Educational Committee of China, grant number LJ232410164021 to Huiyan Zhou and the Science and Technology Project of Hunan Province, grant number 2023JJ40882 to Jiong Li.
Abstract
Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by the accumulation of synovial fluid in joints, synovial inflammation, and cartilage damage. With the development of the disease, it may result in joint deformity, which affects the normal joint function of patients and seriously endangers peopleʼs life and health. According to statistics, the incidence of rheumatoid arthritis increases with age. However, there is currently no drug that can completely cure rheumatoid arthritis; only through certain drugs and measures can the progression of the disease be delayed. Plant-derived bioactive substances have garnered extensive research attention for their therapeutic potential in treating various diseases. Studies have shown that plant-derived bioactive substances play an important role in preventing rheumatoid arthritis. This review comprehensively and systematically evaluates plant-derived bioactive substances with anti-arthritic properties, specifically focusing on bioactive substances including flavonoids, polyphenols, terpenes, alkaloids, phenols, quinones, and phenylpropanoids, and elucidates their mechanisms of action to provide reference for the prevention and treatment of rheumatoid arthritis.
Publication History
Received: 12 December 2024
Accepted after revision: 29 May 2025
Article published online:
04 November 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 DʼOrazio A, Cirillo AL, Greco G, Di Ruscio E, Latorre M, Pisani F, Alunno A, Puxeddu I. Pathogenesis of rheumatoid arthritis: One year in review 2024. Clin Exp Rheumatol 2024; 42: 1707-1713
- 2 Zheng Y, Wei K, Jiang P, Zhao J, Shan Y, Shi Y, Zhao F, Chang C, Li Y, Zhou M, Lv X, Guo S, He D. Macrophage polarization in rheumatoid arthritis: Signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts. Front Immunol 2024; 15: 1394108
- 3 Dibrov DA, Avdeeva AS, Diatroptov ME, Nasonov EL. Anti-Carbamylated Protein Antibodies in ACPA-negative and ACPA-positive patients with Rheumatoid arthritis. Dokl Biochem Biophys 2024; 517: 235-242
- 4 Perera J, Delrosso CA, Nerviani A, Pitzalis C. Clinical phenotypes, serological biomarkers, and synovial features defining seropositive and seronegative rheumatoid arthritis: A literature review. Cells 2024; 13: 743
- 5 Inchingolo F, Inchingolo AM, Fatone MC, Avantario P, Del Vecchio G, Pezzolla C, Mancini A, Galante F, Palermo A, Inchingolo AD, Dipalma G. Management of rheumatoid arthritis in primary care: A scoping review. Int J Environ Res Public Health 2024; 21: 662
- 6 Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 2022; 18: 591-602
- 7 Ma Y, Chen H, Lv W, Wei S, Zou Y, Li R, Wang J, She W, Yuan L, Tao J, Guo X, Bi S, Tian H, Ma Y, Sun H, Sun C, Xu J, Dong Y, Kang J, Lv H, Zhang M, Jiang Y. Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: A systematic and comprehensive analysis of the Global Burden of Disease study 2021. Biomark Res 2025; 13: 47
- 8 Alam J, Jantan I, Bukhari SNA. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy. Biomed Pharmacother 2017; 92: 615-633
- 9 Makkar R, Behl T, Kumar A, Nijhawan P, Arora S. Emerging therapeutic effects of herbal plants in rheumatoid arthritis. Endocr Metab Immune Disord Drug Targets 2021; 21: 617-625
- 10 Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 2001; 109: 69-75
- 11 Liu T, Chen X. Bioactive compounds from natural sources: Discovery, evaluation, and applications. Molecules (Basel, Switzerland) 2024; 29: 3209
- 12 Das G, Patra JK, Kang SS, Shin HS. Pharmaceutical importance of some promising plant species with special reference to the isolation and extraction of bioactive compounds: A review. Curr Pharm Biotechnol 2022; 23: 15-29
- 13 Gallotti FCM, Serafini MR, Thomazzi SM. Scenario of the treatment of arthritis with natural products. Recent Pat Inflamm Allergy Drug Discov 2020; 14: 95-105
- 14 Dixit T, Vaidya A, Ravindran S. Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. Future Sci OA 2025; 11: 2467591
- 15 Narayanankutty A, Famurewa AC, Oprea E. Natural bioactive compounds and human health. Molecules (Basel, Switzerland) 2024; 29: 3372
- 16 Tanvir R, Guo L, Wu H, Li L. Special issue: Manipulation/regulation of secondary metabolites in medicinal plants. Plant Physiol Biochem 2024; 211: 108549
- 17 Hamed MA, Aboul Naser AF, Aboutabl ME, Osman AF, Hassan EES, Aziz WM, Khalil WKB, Farghaly AA, El-Hagrassi AM. Bioactive compounds and therapeutic role of Brassica oleracea L. seeds in rheumatoid arthritis rats via regulating inflammatory signalling pathways and antagonizing interleukin-1 receptor action. Biomarkers 2021; 26: 788-807
- 18 Ahmed AH, Abd Elkarim AS. Bioactive compounds with significant anti- rheumatoid arthritis effect isolated for the first time from leaves of Bougainvillea spectabilis . Curr Pharm Biotechnol 2021; 22: 2048-2053
- 19 Mendie LE, Hemalatha S. Bioactive compounds from nyctanthes arbor tristis linn as potential inhibitors of Janus Kinases (JAKs) involved in rheumatoid arthritis. Appl Biochem Biotechnol 2023; 195: 314-330
- 20 Sharma VK, Prateeksha P, Singh SP, Rao CV, Singh BN. Nyctanthes arbor-tristis bioactive extract ameliorates LPS-induced inflammation through the inhibition of NF-κB signalling pathway. J Ethnopharmacol 2024; 320: 117382
- 21 Lakshmanan DK, Murugesan S, Rajendran S, Ravichandran G, Elangovan A, Raju K, Prathiviraj R, Pandiyan R, Thilagar S. Brassica juncea (L.) Czern. leaves alleviate adjuvant-induced rheumatoid arthritis in rats via modulating the finest disease targets – IL2RA, IL18 and VEGFA. J Biomol Struct Dyn 2022; 40: 8155-8168
- 22 Karwasra R, Singh S, Sharma D, Sharma S, Sharma N, Khanna K. Pomegranate supplementation attenuates inflammation, joint dysfunction via inhibition of NF-κB signaling pathway in experimental models of rheumatoid arthritis. J Food Biochem 2019; 43: e12959
- 23 Blin JA, Hamid RA, Khazaʼai H. Bioactive fractions and compound of Ardisia crispa roots exhibit anti-arthritic properties mediated via angiogenesis inhibition in vitro. BMC Complement Med Ther 2021; 21: 176
- 24 Tang M, Zeng Y, Peng W, Xie X, Yang Y, Ji B, Li F. Pharmacological aspects of natural quercetin in rheumatoid arthritis. Drug Des Devel Ther 2022; 16: 2043-2053
- 25 Xiao P, Hao Y, Zhu X, Wu X. p 53 contributes to quercetin-induced apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes. Inflammation 2013; 36: 272-278
- 26 Zhao J, Chen B, Peng X, Wang C, Wang K, Han F, Xu J. Quercetin suppresses migration and invasion by targeting miR-146a/GATA6 axis in fibroblast-like synoviocytes of rheumatoid arthritis. Immunopharmacol Immunotoxicol 2020; 42: 221-227
- 27 Sun HT, Li JP, Qian WQ, Yin MF, Yin H, Huang GC. Quercetin suppresses inflammatory cytokine production in rheumatoid arthritis fibroblast-like synoviocytes. Exp Ther Med 2021; 22: 1260
- 28 Yang Y, Zhang X, Xu M, Wu X, Zhao F, Zhao C. Quercetin attenuates collagen-induced arthritis by restoration of Th17/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int Immunopharmacol 2018; 54: 153-162
- 29 Saccol R, da Silveira KL, Adefegha SA, Manzoni AG, da Silveira LL, Coelho APV, Castilhos LG, Abdalla FH, Becker LV, Martins NMB, Oliveira JS, Casali EA, Leal DBR. Effect of quercetin on E-NTPDase/E-ADA activities and cytokine secretion of complete Freund adjuvant-induced arthritic rats. Cell Biochem Funct 2019; 37: 474-485
- 30 Guazelli CFS, Staurengo-Ferrari L, Zarpelon AC, Pinho-Ribeiro FA, Ruiz-Miyazawa KW, Vicentini F, Vignoli JA, Camilios-Neto D, Georgetti SR, Baracat MM, Casagrande R, Verri jr. WA. Quercetin attenuates zymosan-induced arthritis in mice. Biomed Pharmacother 2018; 102: 175-184
- 31 Cho JW, Cho SY, Lee SR, Lee KS. Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo. Int J Mol Med 2010; 25: 347-352
- 32 Tan H, Liang D, Lu N, Zhang J, Zhang S, Tan G. Mangiferin attenuates lipopolysaccharide-induced neuronal injuries in primary cultured hippocampal neurons. Aging 2024; 16: 8645-8656
- 33 Akkewar AS, Mishra KA, Sethi KK. Mangiferin: A natural bioactive immunomodulating glucosylxanthone with potential against cancer and rheumatoid arthritis. J Biochem Mol Toxicol 2024; 38: e23765
- 34 Henc I, Kokotkiewicz A, Łuczkiewicz P, Bryl E, Łuczkiewicz M, Witkowski JM. Naturally occurring xanthone and benzophenone derivatives exert significant anti-proliferative and proapoptotic effects in vitro on synovial fibroblasts and macrophages from rheumatoid arthritis patients. Int Immunopharmacol 2017; 49: 148-154
- 35 Wang R, Liu J, Wang Z, Wu X, Guo H, Jiao X, Zhang H, Qi C, Li X. Mangiferin exert protective effects on joints of adjuvant-induced arthritis rats by regulating the MAPKs/NF-κB pathway of fibroblast-like synoviocytes. Int Immunopharmacol 2021; 101: 108352
- 36 Li W, Wang K, Liu Y, Wu H, He Y, Li C, Wang Q, Su X, Yan S, Su W, Zhang Y, Lin N. A novel drug combination of mangiferin and cinnamic acid alleviates rheumatoid arthritis by inhibiting TLR4/NFκB/NLRP3 activation-induced pyroptosis. Front Immunol 2022; 13: 912933
- 37 Mao X, Liu Y, Li W, Wang K, Li C, Wang Q, Chen W, Ma Z, Wang X, Ding Z, Zhang Y, Lin N. A promising drug combination of mangiferin and glycyrrhizic acid ameliorates disease severity of rheumatoid arthritis by reversing the disturbance of thermogenesis and energy metabolism. Phytomedicine 2022; 104: 154216
- 38 Su L, Wei ZF, Pi CC, Qin TX, Song F, Zhang YW, Gao SJ. Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation. Phytomedicine 2024; 132: 155901
- 39 Wei CC, Ping DQ, You FT, Qiang CY, Tao C. Icariin prevents cartilage and bone degradation in experimental models of arthritis. Mediators Inflamm 2016; 2016: 9529630
- 40 Chi L, Gao W, Shu X, Lu X. A natural flavonoid glucoside, icariin, regulates Th17 and alleviates rheumatoid arthritis in a murine model. Mediators Inflamm 2014; 2014: 392062
- 41 Sun P, Liu Y, Deng X, Yu C, Dai N, Yuan X, Chen L, Yu S, Si W, Wang X, Wu D, Liu S, Pang H. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. Phytomedicine 2013; 20: 975-979
- 42 Wu Z, Liu Q, Cao Z, Li H, Zhou Y, Zhang P. Icariin decreases cell proliferation and inflammation of rheumatoid arthritis-fibroblast like synoviocytes via GAREM1/MAPK signaling pathway. Immunopharmacol Immunotoxicol 2024; 46: 86-92
- 43 Wu ZM, Xiang YR, Zhu XB, Shi XD, Chen S, Wan X, Guo J. Icariin represses the inflammatory responses and survival of rheumatoid arthritis fibroblast-like synoviocytes by regulating the TRIB1/TLR2/NF-kB pathway. Int Immunopharmacol 2022; 110: 108991
- 44 Wu ZM, Luo J, Shi XD, Zhang SX, Zhu XB, Guo J. Icariin alleviates rheumatoid arthritis via regulating miR-223-3 p/NLRP3 signalling axis. Autoimmunity 2020; 53: 450-458
- 45 Li M, Yu X, Chen X, Jiang Y, Zeng Y, Ren R, Nie M, Zhang Z, Bao Y, Kang H. Genkwanin alleviates intervertebral disc degeneration via regulating ITGA2/PI3K/AKT pathway and inhibiting apoptosis and senescence. Int Immunopharmacol 2024; 133: 112101
- 46 Sun YW, Bao Y, Yu H, Chen QJ, Lu F, Zhai S, Zhang CF, Li F, Wang CZ, Yuan CS. Anti-rheumatoid arthritis effects of flavonoids from Daphne genkwa. Int Immunopharmacol 2020; 83: 106384
- 47 Zhang CF, Zhang SL, He X, Yang XL, Wu HT, Lin BQ, Jiang CP, Wang J, Yu CH, Yang ZL, Wang CZ, Li P, Yuan CS. Antioxidant effects of Genkwa flos flavonoids on Freundʼs adjuvant-induced rheumatoid arthritis in rats. J Ethnopharmacol 2014; 153: 793-800
- 48 Bao Y, Sun YW, Ji J, Gan L, Zhang CF, Wang CZ, Yuan CS. Genkwanin ameliorates adjuvant-induced arthritis in rats through inhibiting JAK/STAT and NF-kB signaling pathways. Phytomedicine 2019; 63: 153036
- 49 Lu T, Feng Z, Xue H, Jin C, Zhang Y, Ai Y, Zheng M, Shi D, Song K. Network pharmacology analysis and experimental validation of tectoridin in the treatment of ischemic stroke by inhibiting apoptosis and regulating inflammation. Int J Mol Sci 2025; 26: 1402
- 50 Huang Q, Xiao X, Yu J, Yang Y, Yu J, Liu Y, Song H, Han T, Zhang D, Niu X, Li W. Tectoridin exhibits anti-rheumatoid arthritis activity through the inhibition of the inflammatory response and the MAPK pathway in vivo and in vitro. Arch Biochem Biophys 2022; 727: 109328
- 51 Niu X, Song H, Xiao X, Yang Y, Huang Q, Yu J, Yu J, Liu Y, Han T, Zhang D, Li W. Tectoridin ameliorates proliferation and inflammation in TNF-α-induced HFLS-RA cells via suppressing the TLR4/NLRP3/NF-κB signaling pathway. Tissue Cell 2022; 77: 101826
- 52 Wang X, Wang Y, Chen J, Wang Q, Liu Z, Yin Y, Yang T, Shen T, Sa Y. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation. Sci Rep 2024; 14: 10114
- 53 Wang J, Chen S, Zhang J, Wu J. Scutellaria baicalensis georgi is a promising candidate for the treatment of autoimmune diseases. Front Pharmacol 2022; 13: 946030
- 54 Lin CM, Chang H, Chen YH, Li SY, Wu IH, Chiu JH. Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol 2006; 6: 1690-1698
- 55 Huang Y, Guo L, Chitti R, Sreeharsha N, Mishra A, Gubbiyappa SK, Singh Y. Wogonin ameliorate complete Freundʼs adjuvant induced rheumatoid arthritis via targeting NF-κB/MAPK signaling pathway. BioFactors (Oxford) 2020; 46: 283-291
- 56 Yang H, Liu C, Lin X, Li X, Zeng S, Gong Z, Xu Q, Li D, Li N. Wogonin inhibits the migration and invasion of fibroblast-like synoviocytes by targeting PI3K/AKT/NF-κB pathway in rheumatoid arthritis. Arch Biochem Biophys 2024; 755: 109965
- 57 Lei H, Ruan Y, Ding R, Li H, Zhang X, Ji X, Wang Q, Lv S. The role of celastrol in inflammation and diseases. Inflamm Res 2025; 74: 23
- 58 Faustino C, Pinheiro L, Duarte N. Triterpenes as potential drug candidates for rheumatoid arthritis treatment. Life (Basel) 2023; 13: 1514
- 59 Jing M, Yang J, Zhang L, Liu J, Xu S, Wang M, Zhang L, Sun Y, Yan W, Hou G, Wang C, Xin W. Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis. Int Immunopharmacol 2021; 98: 107879
- 60 Shirai T, Nakai A, Ando E, Fujimoto J, Leach S, Arimori T, Higo D, van Eerden FJ, Tulyeu J, Liu YC, Okuzaki D, Murayama MA, Miyata H, Nunomura K, Lin B, Tani A, Kumanogoh A, Ikawa M, Wing JB, Standley DM, Takagi J, Suzuki K. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex. Science immunology 2023; 8: eadc9324
- 61 Yang J, Liu J, Li J, Jing M, Zhang L, Sun M, Wang Q, Sun H, Hou G, Wang C, Xin W. Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K/AKT/mTOR signaling pathway. Int Immunopharmacol 2022; 112: 109241
- 62 Deng J, Wang K, Yang J, Wang A, Chen G, Ye M, Chen Q, Lin D. β-Caryophyllene promotes the survival of random skin flaps by upregulating the PI3K/AKT signaling pathway. Phytomedicine 2024; 130: 155726
- 63 El-Sheikh SMA, Abd El-Alim AEF, Galal AAA, El-Sayed RG, El-Naseery NI. Anti-arthritic effect of β-caryophyllene and its ameliorative role on methotrexate and/or leflunomide-induced side effects in arthritic rats. Life Sci 2019; 233: 116750
- 64 Iqbal U, Malik A, Sial NT, Uttra AM, Rehman MFU, Mehmood MH. Molecular insights of Eucalyptol (1, 8-Cineole) as an anti-arthritic agent: in vivo and in silico analysis of IL-17, IL-10, NF-κB, 5-LOX and COX-2. Inflammopharmacology 2024; 32: 1941-1959
- 65 Barros Silva Soares de Souza EP, Trindade G, Lins Dantas Gomes MV, Santos Silva LA, Grespan R, Quintans Junior LJ, Cavalcanti de Albuquerque Júnior RL, Shanmugan S, Antunes de Souza Araújo A. Anti-inflammatory effect of nano-encapsulated nerolidol on zymosan-induced arthritis in mice. Food Chem Toxicol 2020; 135: 110958
- 66 de Souza EPBSS, Gomes MVLD, Dos Santos Lima B, Silva LAS, Shanmugan S, Cavalcanti MD, de Albuquerque Júnior RLC, de Souza Carvalho FM, Marreto RN, de Lima CM, Júnior LJQ, de Souza Araújo AA. Nerolidol-beta-cyclodextrin inclusion complex enhances anti-inflammatory activity in arthritis model and improves gastric protection. Life Sci 2021; 265: 118742
- 67 Akhter S, Irfan HM, Alamgeer, Jahan S, Shahzad M, Latif MB. Nerolidol: A potential approach in rheumatoid arthritis through reduction of TNF-α, IL-1β, IL-6, NF-κB, COX-2 and antioxidant effect in CFA-induced arthritic model. Inflammopharmacology 2022; 30: 537-548
- 68 Ali MY, Akter Z, Mei Z, Zheng M, Tania M, Khan MA. Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms. Biomed Pharmacother 2021; 134: 111157
- 69 Zielińska M, Dereń K, Polak-Szczybyło E, Stępień AE. The role of bioactive compounds of Nigella sativa in rheumatoid arthritis therapy-current reports. Nutrients 2021; 13: 3369
- 70 Umar S, Zargan J, Umar K, Ahmad S, Katiyar CK, Khan HA. Modulation of the oxidative stress and inflammatory cytokine response by thymoquinone in the collagen induced arthritis in Wistar rats. Chem Biol Interact 2012; 197: 40-46
- 71 Pal RR, Rajpal V, Singh P, Saraf SA. Recent findings on thymoquinone and its applications as a nanocarrier for the treatment of cancer and rheumatoid arthritis. Pharmaceutics 2021; 13: 775
- 72 Arjumand S, Shahzad M, Shabbir A, Yousaf MZ. Thymoquinone attenuates rheumatoid arthritis by downregulating TLR2, TLR4, TNF-α, IL-1, and NFκB expression levels. Biomed Pharmacother 2019; 111: 958-963
- 73 Marrelli M, Amodeo V, Perri MR, Conforti F, Statti G. Essential oils and bioactive components against arthritis: A novel perspective on their therapeutic potential. Plants (Basel, Switzerland) 2020; 9: 1252
- 74 Huang GJ, Pan CH, Wu CH. Sclareol exhibits anti-inflammatory activity in both lipopolysaccharide-stimulated macrophages and the λ-carrageenan-induced paw edema model. J Nat Prod 2012; 75: 54-59
- 75 Zhong Y, Huang Y, Santoso MB, Wu LD. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model. Int J Clin Exp Pathol 2015; 8: 2365-2374
- 76 Tsai SW, Hsieh MC, Li S, Lin SC, Wang SP, Lehman CW, Lien CZ, Lin CC. Therapeutic potential of sclareol in experimental models of rheumatoid arthritis. Int J Mol Sci 2018; 19: 1351
- 77 Hao J, Qi F, Wang H, Su L, Li X, Zhang N, Sun W, Wei W. Network pharmacology-based prediction of inhibiting leukocyte recruitment and angiogenesis of total glucosides of peony against rheumatoid arthritis. Ann Palliat Med 2022; 11: 3085-3101
- 78 Xin Q, Yuan R, Shi W, Zhu Z, Wang Y, Cong W. A review for the anti-inflammatory effects of paeoniflorin in inflammatory disorders. Life Sci 2019; 237: 116925
- 79 Ma J, Meng Q, Zhan J, Wang H, Fan W, Wang Y, Zhang S, Bian H, Zheng F. Paeoniflorin suppresses rheumatoid arthritis development via modulating the Circ-FAM120A/miR-671–5 p/MDM4 axis. Inflammation 2021; 44: 2309-2322
- 80 Yang F, Shen J, Cai H. [Paeoniflorin inhibits Wnt1/β-catenin pathway and promotes apoptosis of fibroblast-like synoviocytes in patients with rheumatoid arthritis by upregulating lncRNA MALAT1]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2022; 38: 692-698
- 81 Meng J, Zhang W, Wang C, Zhang W, Zhou C, Jiang G, Hong J, Yan S, Yan W. Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. Biochem Pharmacol 2020; 171: 113715
- 82 Di Y, Zhang M, Chen Y, Sun R, Shen M, Tian F, Yang P, Qian F, Zhou L. Catalpol inhibits Tregs-to-Th17 cell transdifferentiation by up-regulating Let-7 g-5 p to Reduce STAT3 protein levels. Yonsei Med J 2022; 63: 56-65
- 83 He Z, Li P, Liu P, Xu P. Exploring stachydrine: From natural occurrence to biological activities and metabolic pathways. Front Plant Sci 2024; 15: 1442879
- 84 Meng J, Zhou C, Zhang W, Wang W, He B, Hu B, Jiang G, Wang Y, Hong J, Li S, He J, Yan S, Yan W. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling. J Cell Mol Med 2019; 23: 6730-6743
- 85 Qin Z, Tang R, Liang J, Jia X. Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases. Int Immunopharmacol 2024; 137: 112422
- 86 Zhang L, Tan M, Mao J, Zhang J, Wang XY, Zhang Y, Duo RX, Hao JY, Shen HL. Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis. Clin Rheumatol 2024; 43: 959-969
- 87 Shen P, Jiao Y, Miao L, Chen JH, Momtazi-Borojeni AA. Immunomodulatory effects of berberine on the inflamed joint reveal new therapeutic targets for rheumatoid arthritis management. J Cell Mol Med 2020; 24: 12234-12245
- 88 Li Z, Chen M, Wang Z, Fan Q, Lin Z, Tao X, Wu J, Liu Z, Lin R, Zhao C. Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis. Bone Joint Res 2023; 12: 91-102
- 89 Cheng JW, Yu Y, Zong SY, Cai WW, Wang Y, Song YN, Xian H, Wei F. Berberine ameliorates collagen-induced arthritis in mice by restoring macrophage polarization via AMPK/mTORC1 pathway switching glycolytic reprogramming. Int Immunopharmacol 2023; 124: 111024
- 90 Dinesh P, Rasool M. Berberine mitigates IL-21/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17/Treg imbalance in rheumatoid arthritis. Apoptosis 2019; 24: 644-661
- 91 Wang H, Tu S, Yang S, Shen P, Huang Y, Ba X, Lin W, Huang Y, Wang Y, Qin K, Chen Z. Berberine modulates LPA function to inhibit the proliferation and inflammation of FLS-RA via p 38/ERK MAPK pathway mediated by LPA(1). Evid Based Complement Alternat Med 2019; 2019: 2580207
- 92 Sujitha S, Dinesh P, Rasool M. Berberine encapsulated PEG-coated liposomes attenuate Wnt1/β-catenin signaling in rheumatoid arthritis via miR-23a activation. Eur J Pharm Biopharm 2020; 149: 170-191
- 93 Jiang S, Li S, Pang S, Liu M, Sun H, Zhang N, Liu J. A systematic review: Sinomenine. Heliyon 2024; 10: e29976
- 94 Li J, Cao J, Chen Q, Liu D, Li R. Investigating the therapeutic potential of sinomenine in rheumatoid arthritis: Anti-inflammatory, antioxidant, and immunomodulatory mechanisms. Naunyn Schmiedebergs Arch Pharmacol 2024; 397: 3945-3958
- 95 Luo J, Zhu Y, Yu Y, Chen Y, He K, Liu J. Sinomenine treats rheumatoid arthritis by inhibiting MMP9 and inflammatory cytokines expression: bioinformatics analysis and experimental validation. Sci Rep 2024; 14: 12786
- 96 Li JM, Yao YD, Luo JF, Liu JX, Lu LL, Liu ZQ, Dong Y, Xie Y, Zhou H. Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review. Phytomedicine 2023; 121: 155114
- 97 Li JM, Deng HS, Yao YD, Wang WT, Hu JQ, Dong Y, Wang PX, Liu L, Liu ZQ, Xie Y, Lu LL, Zhou H. Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways. Acta Pharmacol Sin 2023; 44: 2504-2524
- 98 Feng ZT, Yang T, Hou XQ, Wu HY, Feng JT, Ou BJ, Cai SJ, Li J, Mei ZG. Sinomenine mitigates collagen-induced arthritis mice by inhibiting angiogenesis. Biomed Pharmacother 2019; 113: 108759
- 99 Jiang ZM, Zeng SL, Huang TQ, Lin Y, Wang FF, Gao XJ, Li J, Li P, Liu EH. Sinomenine ameliorates rheumatoid arthritis by modulating tryptophan metabolism and activating aryl hydrocarbon receptor via gut microbiota regulation. Sci Bull (Beijing) 2023; 68: 1540-1555
- 100 Liu S, Sun C, Tang H, Peng C, Peng F. Leonurine: a comprehensive review of pharmacokinetics, pharmacodynamics, and toxicology. Front Pharmacol 2024; 15: 1428406
- 101 Ma XN, Feng W, Li N, Chen SL, Zhong XQ, Chen JX, Lin CS, Xu Q. Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway. Phytomedicine 2024; 123: 155243
- 102 Du YY, Chen ZX, Liu MY, Liu QP, Lin CS, Chu CQ, Xu Q. Leonurine regulates Treg/Th17 balance to attenuate rheumatoid arthritis through inhibition of TAZ expression. Front Immunol 2020; 11: 556526
- 103 Chu L, Zhuo J, Huang H, Chen W, Zhong W, Zhang J, Meng X, Zou F, Cai S, Zou M, Dong H. Tetrandrine alleviates pulmonary fibrosis by inhibiting alveolar epithelial cell senescence through PINK1/Parkin-mediated mitophagy. Eur J Pharmacol 2024; 969: 176459
- 104 Xu J, Li J, Ye Y, Zhao Q, Lyu D. Efficacy and safety of tetrandrine in treatment of rheumatoid arthritis: A meta analysis. Zhejiang Da Xue Xue Bao Yi Xue Ban 2024; 53: 519-526
- 105 Gao LN, Feng QS, Zhang XF, Wang QS, Cui YL. Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-κB inactivation. J Orthop Res 2016; 34: 1557-1568
- 106 Li X, Wu Z, He B, Zhong W. Tetrandrine alleviates symptoms of rheumatoid arthritis in rats by regulating the expression of cyclooxygenase-2 and inflammatory factors. Exp Ther Med 2018; 16: 2670-2676
- 107 Gao P, Rao ZW, Li M, Sun XY, Gao QY, Shang TZ, Chen C, Zhang CL. Tetrandrine represses inflammation and attenuates osteoarthritis by selective inhibition of COX-2. Curr Med Sci 2023; 43: 505-513
- 108 Duan B, Yu Z, Liu R, Li J, Song Z, Zhou Q, Chen L. Tetrandrine-induced downregulation of lncRNA NEAT1 inhibits rheumatoid arthritis progression through the STAT3/miR-17-5 p pathway. Immunopharmacol Immunotoxicol 2022; 44: 886-893
- 109 Ilic NM, Dey M, Poulev AA, Logendra S, Kuhn PE, Raskin I. Anti-inflammatory activity of grains of paradise (Aframomum melegueta Schum) extract. J Agric Food Chem 2014; 62: 10452-10457
- 110 Sharma S, Shukla MK, Sharma KC, Tirath, Kumar L, Anal JMH, Upadhyay SK, Bhattacharyya S, Kumar D. Revisiting the therapeutic potential of gingerols against different pharmacological activities. Naunyn Schmiedebergs Arch Pharmacol 2023; 396: 633-647
- 111 Ballester P, Cerdá B, Arcusa R, Marhuenda J, Yamedjeu K, Zafrilla P. Effect of ginger on inflammatory diseases. Molecules (Basel, Switzerland) 2022; 27: 7223
- 112 Li N, Li X, Deng L, Yang H, Gong Z, Wang Q, Pan D, Zeng S, Chen J. 6-Shogaol inhibits the proliferation, apoptosis, and migration of rheumatoid arthritis fibroblast-like synoviocytes via the PI3K/AKT/NF-κB pathway. Phytomedicine 2023; 109: 154562
- 113 Bischoff-Kont I, Primke T, Niebergall LS, Zech T, Fürst R. Ginger constituent 6-shogaol inhibits inflammation- and angiogenesis-related cell functions in primary human endothelial cells. Front Pharmacol 2022; 13: 844767
- 114 Jo S, Samarpita S, Lee JS, Lee YJ, Son JE, Jeong M, Kim JH, Hong S, Yoo SA, Kim WU, Rasool M, Byun S. 8-shogaol inhibits rheumatoid arthritis through targeting TAK1. Pharmacol Res 2022; 178: 106176
- 115 Liu Z, Wei J, Sun H, Xu L. Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1-Nrf2/HO-1 signalling pathways. J Cell Mol Med 2024; 28: e18386
- 116 Yadav AM, Bagade MM, Ghumnani S, Raman S, Saha B, Kubatzky KF, Ashma R. The phytochemical plumbagin reciprocally modulates osteoblasts and osteoclasts. Biol Chem 2022; 403: 211-229
- 117 Shu C, Chen J, Lv M, Xi Y, Zheng J, Xu X. Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway. Bioengineered 2022; 13: 13632-13642
- 118 Li X, Lei Y, Gao Z, Wu G, Gao W, Xia L, Lu J, Shen H. IL-34 affects fibroblast-like synoviocyte proliferation, apoptosis and function by regulating IL-17. Sci Rep 2021; 11: 16378
- 119 Wang XH, Shen CP, Wang TT, Huang Y, Jin Y, Zhou MY, Zhang MY, Gu SL, Wang MQ, Liu ZC, Li R, Cai L. Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via modulation of the AMPK/mTOR/ULK-1 signaling pathway. Phytomedicine 2024; 128: 155512
- 120 Kim YO, Hong SJ, Yim SV. The efficacy of shikonin on cartilage protection in a mouse model of rheumatoid arthritis. Korean J Physiol Pharmacol 2010; 14: 199-204
- 121 Liu C, He L, Wang J, Wang Q, Sun C, Li Y, Jia K, Wang J, Xu T, Ming R, Wang Q, Lin N. Anti-angiogenic effect of shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. J Ethnopharmacol 2020; 260: 113039
- 122 Liu FY, Wang MQ, Liu MM, Li T, Wang XH, Jiang F, Wu XJ, Cheng J, Cai L, Li R. Therapeutic effects of shikonin on adjuvant-induced arthritis in rats and cellular inflammation, migration and invasion of rheumatoid fibroblast-like synoviocytes via blocking the activation of Wnt/β-catenin pathway. Phytomedicine 2023; 116: 154857
- 123 He L, Luan H, He J, Zhang M, Qin Q, Hu Y, Cai Y, Sun D, Shi Y, Wang Q. Shikonin attenuates rheumatoid arthritis by targeting SOCS1/JAK/STAT signaling pathway of fibroblast like synoviocytes. Chin Med 2021; 16: 96
- 124 Lianhua HE, Huijie L, Qingxia Q, Juan HE, Jian C, Yiping HU, Yueming C, Desheng S, Yu S, Qingwen W. Shikonin alleviates collagen-induced arthritis mice by inhibiting M1 macrophage polarization. J Tradit Chin Med 2022; 42: 932-939
- 125 Cheng L, Chen J, Rong X. Mechanism of emodin in the treatment of rheumatoid arthritis. Evid Based Complement Alternat Med 2022; 2022: 9482570
- 126 Hwang JK, Noh EM, Moon SJ, Kim JM, Kwon KB, Park BH, You YO, Hwang BM, Kim HJ, Kim BS, Lee SJ, Kim JS, Lee YR. Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice. Rheumatology (Oxford) 2013; 52: 1583-1591
- 127 Zhu M, Yuan K, Lu Q, Zhu Q, Zhang S, Li X, Zhao L, Wang H, Luo G, Wang T, Huang G, Xu A. Emodin ameliorates rheumatoid arthritis by promoting neutrophil apoptosis and inhibiting neutrophil extracellular trap formation. Mol Immunol 2019; 112: 188-197
- 128 Safaeian L, Asghari-Varzaneh M, Alavi SS, Halvaei-Varnousfaderani M, Laher I. Cardiovascular protective effects of cinnamic acid as a natural phenolic acid: A review. Arch Physiol Biochem 2025; 131: 52-62
- 129 Pahan S, Raha S, Dasarathi S, Pahan K. Cinnamein Inhibits the induction of nitric oxide and proinflammatory cytokines in macrophages, microglia and astrocytes. J Clin Exp Immunol 2023; 8: 520-529
- 130 Lao Y, Guo J, Fang J, Geng R, Li M, Qin Y, Wu J, Kang SG, Huang K, Tong T. Beyond flavor: The versatile roles of eugenol in health and disease. Food Funct 2024; 15: 10567-10581
- 131 Wang M, Dai T, Li S, Wang W. Eugenol suppresses the proliferation and invasion of TNF-α-induced fibroblast-like synoviocytes via regulating NF-κB and COX-2. Biochem Biophys Res Commun 2022; 612: 63-69
- 132 Jabbari N, Eftekhari Z, Roodbari NH, Parivar K. Evaluation of encapsulated eugenol by chitosan nanoparticles on the aggressive model of rheumatoid arthritis. Int Immunopharmacol 2020; 85: 106554
- 133 Tang M, Xie X, Yi P, Kang J, Liao J, Li W, Li F. Integrating network pharmacology with molecular docking to unravel the active compounds and potential mechanism of Simiao pill treating rheumatoid arthritis. Evid Based Complement Alternat Med 2020; 2020: 5786053
- 134 Liu X, Wang Z, Qian H, Tao W, Zhang Y, Hu C, Mao W, Guo Q. Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol 2022; 13: 945129
- 135 Wang Y, Chen S, Du K, Liang C, Wang S, Owusu Boadi E, Li J, Pang X, He J, Chang YX. Traditional herbal medicine: Therapeutic potential in rheumatoid arthritis. J Ethnopharmacol 2021; 279: 114368
- 136 Lv QW, Zhang W, Shi Q, Zheng WJ, Li X, Chen H, Wu QJ, Jiang WL, Li HB, Gong L, Wei W, Liu H, Liu AJ, Jin HT, Wang JX, Liu XM, Li ZB, Liu B, Shen M, Wang Q, Wu XN, Liang D, Yin YF, Fei YY, Su JM, Zhao LD, Jiang Y, Li J, Tang FL, Zhang FC, Lipsky PE, Zhang X. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): A randomised, controlled clinical trial. Ann Rheum Dis 2015; 74: 1078-1086
- 137 Luo J, Jin DE, Yang GY, Zhang YZ, Wang JM, Kong WP, Tao QW. Total glucosides of paeony for rheumatoid arthritis: A systematic review of randomized controlled trials. Complement Ther Med 2017; 34: 46-56
